JP2005517030A - ビスピリジニウムアルカンに基づく水性防腐薬 - Google Patents
ビスピリジニウムアルカンに基づく水性防腐薬 Download PDFInfo
- Publication number
- JP2005517030A JP2005517030A JP2003567186A JP2003567186A JP2005517030A JP 2005517030 A JP2005517030 A JP 2005517030A JP 2003567186 A JP2003567186 A JP 2003567186A JP 2003567186 A JP2003567186 A JP 2003567186A JP 2005517030 A JP2005517030 A JP 2005517030A
- Authority
- JP
- Japan
- Prior art keywords
- preservative
- alcohol
- preservatives
- solution
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003755 preservative agent Substances 0.000 title claims abstract description 73
- 150000001335 aliphatic alkanes Chemical class 0.000 title claims abstract description 17
- 230000002335 preservative effect Effects 0.000 claims abstract description 46
- SMGTYJPMKXNQFY-UHFFFAOYSA-N octenidine dihydrochloride Chemical compound Cl.Cl.C1=CC(=NCCCCCCCC)C=CN1CCCCCCCCCCN1C=CC(=NCCCCCCCC)C=C1 SMGTYJPMKXNQFY-UHFFFAOYSA-N 0.000 claims abstract description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 13
- 206010052428 Wound Diseases 0.000 claims abstract description 9
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 9
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 9
- 229920000136 polysorbate Polymers 0.000 claims abstract description 8
- 229940068965 polysorbates Drugs 0.000 claims abstract description 6
- 238000004140 cleaning Methods 0.000 claims abstract description 4
- 210000004400 mucous membrane Anatomy 0.000 claims abstract description 4
- 229960001774 octenidine Drugs 0.000 claims abstract description 4
- 210000001835 viscera Anatomy 0.000 claims abstract description 4
- 230000000249 desinfective effect Effects 0.000 claims abstract 2
- 239000000243 solution Substances 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 15
- -1 alkyl glycoside Chemical class 0.000 claims description 14
- 239000000644 isotonic solution Substances 0.000 claims description 14
- 230000002421 anti-septic effect Effects 0.000 claims description 9
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 229920000727 Decyl polyglucose Polymers 0.000 claims description 3
- 229930182470 glycoside Natural products 0.000 claims description 3
- 239000002518 antifoaming agent Substances 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 239000002562 thickening agent Substances 0.000 claims description 2
- 239000000080 wetting agent Substances 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 25
- 230000000694 effects Effects 0.000 description 17
- 239000012895 dilution Substances 0.000 description 11
- 238000010790 dilution Methods 0.000 description 11
- 239000011780 sodium chloride Substances 0.000 description 10
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 8
- 229960005323 phenoxyethanol Drugs 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- OAAZUWWNSYWWHG-UHFFFAOYSA-N 1-phenoxypropan-1-ol Chemical compound CCC(O)OC1=CC=CC=C1 OAAZUWWNSYWWHG-UHFFFAOYSA-N 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000008233 hard water Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229940021222 peritoneal dialysis isotonic solution Drugs 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 241000032203 Conus aureus Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 101500021084 Locusta migratoria 5 kDa peptide Proteins 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 229920002257 Plurafac® Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002027 dodecanoic acid esters Chemical class 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000000819 hypertonic solution Substances 0.000 description 1
- 229940021223 hypertonic solution Drugs 0.000 description 1
- 239000000815 hypotonic solution Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 150000002888 oleic acid derivatives Chemical class 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 150000002942 palmitic acid derivatives Chemical class 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- DCNLOVYDMCVNRZ-UHFFFAOYSA-N phenylmercury(.) Chemical class [Hg]C1=CC=CC=C1 DCNLOVYDMCVNRZ-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- AJKIRUJIDFJUKJ-UHFFFAOYSA-N taurolidine Chemical compound C1NS(=O)(=O)CCN1CN1CNS(=O)(=O)CC1 AJKIRUJIDFJUKJ-UHFFFAOYSA-N 0.000 description 1
- 229960004267 taurolidine Drugs 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Dentistry (AREA)
- Pest Control & Pesticides (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Agronomy & Crop Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
b)アルコールポリアルコキシレート、ポリソルベート及びアルキルグリコシドから選択される非イオン性界面活性剤0.01〜20重量%を含有し、並びに1以上の賦形剤を任意に含有することを特徴とする防腐薬、特に等張性防腐薬、及び皮膚、粘膜、創傷又は内臓の防腐性処置のための、皮膚消毒または洗浄溶液としての前記防腐薬の使用。
Description
a)ビスピリジニウムアルカン、特にオクテニジンジヒドロクロライド0.01〜10重量%、及び
b)アルコールポリアルコキシレート、ポリソルベート及びアルキルグリコシドから選択される、非イオン性界面活性剤0.01〜20重量%
を含有し、1以上の賦形剤を任意に含有し得るアルコールフリー、アリールオキシアルコールフリーの防腐薬により達成されることが見出された。
Yは、4〜18の炭素原子を有するアルキレン基であり、
Rは、6〜18の炭素原子を有するアルキル基、または5〜7の炭素原子を有するシクロアルキル基、またはハロゲン原子で置換されたフェニル基であり、及び
Aは、単一のアニオン、又は複数のアニオンである。
オクテニジンジヒドロクロライドに基づく防腐薬の例により示されるように、これらは優れた抗菌活性を有する;本発明による防腐薬には、活性化合物ビスピリジニウムアルカンの既知の製剤(同濃度)と、少なくとも同等の活性がある。
溶液の等張性は、浸透圧計(クナウル(Knaur)のセミオスモメータ)によって、調節した。計測は、氷点降下の測定によって、本装置を用いて行う。
KR=logKBE(Ko)−logKBE(P)
式中、
KBE(Ko)は、上述の防腐薬(希釈物)の作用を伴わない微生物/mlの数であり、
KBE(P)は、上述の防腐薬(溶液)の作用を伴う微生物/ml数であり、及び
KRは、対数の減少率である。
等張性が防腐薬1中にすでに存在する添加剤の含有量の増加によって調節された、例Eに記述した防腐薬4及び5を、一方では硬水中での、もう一方では等張グルコース溶液中での50%濃度の希釈物としてその活性に関して調べた。
次に示す結果は、上述の防腐薬の+8℃での24時間の貯蔵後に得たものである。ここで、NTUは、「比濁分析の濁度単位」を表す(EPA、すなわち米国環境保護庁の規定による90°での測定単位)。20のNTUでさえ、肉眼でわずかに不透明であると認識できる。
Claims (5)
- アルコールフリー、アリールオキシアルコールフリーの防腐薬であって、
a)ビスピリジニウムアルカン、特にオクテニジンジヒドロクドライド0.01〜10重量%、及び
b)アルコールポリアルコキシレート、ポリソルベート及びアルキルグリコシドから選択される非イオン性界面活性剤0.01〜20重量%
を含有し、並びに1以上の賦形剤を任意に含有することを特徴とする防腐薬。 - a)オクテニジンジヒドロクロライド0.01〜2重量%、及び
b)アルキルグリコシド、好ましくはC8〜C20−アルキルポリグルコース、さらに好ましくはココイルポリグルコース、ラウリルポリグルコース若しくはデシルポリグルコース、又はこれらの混合物0.1〜2重量%
を含有することを特徴とする請求項1に記載の防腐薬。 - 前記賦形剤は、湿潤剤、増粘剤、矯味剤、再脂肪化剤、緩衝剤物質、消泡剤及び着色剤から選択されることを特徴とする請求項1または2のいずれか一項に記載の防腐薬。
- 等張溶液として存在することを特徴とする請求項1〜3のいずれか一項に記載の防腐薬。
- 皮膚、粘膜、創傷又は内臓の防腐性処置のための、皮膚消毒または洗浄溶液としての請求項1〜4のいずれか一項に記載の防腐薬の使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10205883A DE10205883A1 (de) | 2002-02-13 | 2002-02-13 | Wässriges Antiseptikum auf Basis von Bispyridiniumalkanen |
PCT/IB2003/000351 WO2003067988A1 (en) | 2002-02-13 | 2003-02-04 | Aqueous antiseptic based on bispyridiniumalkanes |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005517030A true JP2005517030A (ja) | 2005-06-09 |
JP4422487B2 JP4422487B2 (ja) | 2010-02-24 |
Family
ID=27618615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003567186A Expired - Fee Related JP4422487B2 (ja) | 2002-02-13 | 2003-02-04 | ビスピリジニウムアルカンに基づく水性防腐薬 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20050119313A1 (ja) |
EP (1) | EP1476019B1 (ja) |
JP (1) | JP4422487B2 (ja) |
AT (1) | ATE390842T1 (ja) |
DE (2) | DE10205883A1 (ja) |
ES (1) | ES2304519T3 (ja) |
WO (1) | WO2003067988A1 (ja) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006219488A (ja) * | 2005-01-19 | 2006-08-24 | L'air Liquide Sante Internatl | 衛生的な手の消毒および消毒目的の手の洗浄のための組成物 |
JP2009507891A (ja) * | 2005-09-15 | 2009-02-26 | エール・リキード・サンテ(アンテルナスィオナル) | リポソーム中にカプセル化されたオクテニジン二塩酸塩を含有する抗菌製剤 |
JP2010508251A (ja) * | 2006-10-31 | 2010-03-18 | エール・リキード・サンテ(アンテルナスィオナル) | ビスピリジニウムアルカン(オクテニジンジヒドロクロリド)を含有する抗菌活性組成物 |
JP2011513266A (ja) * | 2008-02-28 | 2011-04-28 | エール・リキード・サンテ(アンテルナスィオナル) | 一定量のビスピリジニウムアルカンを含む、抗菌作用を有する安定化された組成物 |
JP2011236211A (ja) * | 2010-05-07 | 2011-11-24 | Ivoclar Vivadent Ag | 抗菌歯科材料 |
JP2012508725A (ja) * | 2008-11-14 | 2012-04-12 | アルタン ホールディング アクチェンゲゼルシャフト | オクテニジン組成物 |
JP2019513793A (ja) * | 2016-04-14 | 2019-05-30 | メリアル インコーポレイテッド | 抗菌性ポリアミド又はオクテニジン保存剤を含むマルチドーズ組成物 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004052308B4 (de) * | 2004-10-12 | 2013-04-04 | Divapharma-Knufinke Arzneimittelwerk Gmbh | Octenidinhaltige Lutschtabletten gegen entzündliche Erkrankungen des Mund- und Rachenraums |
DE102005002644A1 (de) * | 2005-01-19 | 2006-07-20 | Schülke & Mayr GmbH | Zusammensetzungen für die hygienische Händedesinfektion und die desinfizierende Händewaschung |
DE102005058978A1 (de) | 2005-08-26 | 2007-03-29 | Bode Chemie Gmbh & Co. Kg | Wund- und Schleimhautdesinfektionsmittel |
DE102005045145A1 (de) * | 2005-09-15 | 2007-03-29 | Schülke & Mayr GmbH | Verwendung von Octenidindihydrochlorid in halbfesten Zubereitungen |
AU2007214450B2 (en) * | 2006-02-14 | 2011-08-04 | Care Fusion 2200, Inc | Liquid applicator and method for reducing the concentration of by-products from antiseptic |
DE102008011692A1 (de) * | 2008-02-28 | 2009-09-10 | Schülke & Mayr GmbH | Wirkstoffkombination und deren Verwendung |
DE102009049504A1 (de) | 2009-10-15 | 2011-04-21 | Schülke & Mayr GmbH | Wund- und Schleimhautantiseptikum auf der Basis von Bispyridiniumalkanen |
DE102010012638A1 (de) * | 2010-03-23 | 2011-09-29 | Schülke & Mayr GmbH | Behälter mit einem kollabierbaren Aufnahmebehälter und einer desinfizierenden Zusammensetzung |
DE102010025932A1 (de) | 2010-07-02 | 2012-01-05 | Schülke & Mayr GmbH | Antiseptikum auf der Basis von Bispyridiniumalkanen |
DE102011077432A1 (de) | 2011-06-10 | 2012-12-13 | Schülke & Mayr GmbH | Verwendung von Bispyridiniumalkanen zur Abtötung von Sporen |
CN105530926B (zh) * | 2013-09-13 | 2019-07-16 | 3M创新有限公司 | 阳离子防腐剂组合物 |
EP3111958A1 (en) | 2015-06-30 | 2017-01-04 | Pharmbridge Sp. z o.o. | Supramolecular aggregate composed of phosphatidylocholinea and octenidine, compositions comprising (containing) it and metod for obtaining thereof |
PL233480B1 (pl) * | 2017-09-28 | 2019-10-31 | Phytopharm Kleka Spolka Akcyjna | Koncentrat na bazie soli bis[4-(RHN)-1-pirydynio]alkanów w formie hydrożelu oraz sposób jego otrzymywania |
DE102018220624A1 (de) | 2018-11-29 | 2020-06-04 | B. Braun Melsungen Ag | Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden |
DE102018220631A1 (de) | 2018-11-29 | 2020-06-04 | B. Braun Melsungen Ag | Wässrige Zusammensetzung, insbesondere zur Behandlung von Schleimhaut und/oder Wunden |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1533952A (en) * | 1976-02-25 | 1978-11-29 | Sterling Drug Inc | Anti-microbial bis-pyridinium compounds |
US4206215A (en) * | 1976-02-25 | 1980-06-03 | Sterling Drug Inc. | Antimicrobial bis-[4-(substituted-amino)-1-pyridinium]alkanes |
US4420484A (en) * | 1979-08-13 | 1983-12-13 | Sterling Drug Inc. | Basic amino or ammonium antimicrobial agent-polyethylene glycol ester surfactant-betaine and/or amine oxide surfactant compositions and method of use therof |
DE4413686C2 (de) * | 1994-04-20 | 1996-10-24 | Henkel Kgaa | Kationische Zuckertenside, Verfahren zu ihrer Herstellung und deren Verwendung |
DE19647692C2 (de) * | 1996-11-05 | 2002-06-20 | Schuelke & Mayr Gmbh | Waschendes Desinfektionsmittel zur hygienischen und chirurgischen Händedesinfektion |
AUPO690997A0 (en) * | 1997-05-20 | 1997-06-12 | Novapharm Research (Australia) Pty Ltd | Alkylpolyglucosides containing disinfectant compositions active against pseudomonas microorganism |
-
2002
- 2002-02-13 DE DE10205883A patent/DE10205883A1/de not_active Withdrawn
-
2003
- 2003-02-04 AT AT03739600T patent/ATE390842T1/de not_active IP Right Cessation
- 2003-02-04 JP JP2003567186A patent/JP4422487B2/ja not_active Expired - Fee Related
- 2003-02-04 EP EP03739600A patent/EP1476019B1/en not_active Expired - Lifetime
- 2003-02-04 ES ES03739600T patent/ES2304519T3/es not_active Expired - Lifetime
- 2003-02-04 WO PCT/IB2003/000351 patent/WO2003067988A1/en active IP Right Grant
- 2003-02-04 DE DE60320087T patent/DE60320087T2/de not_active Expired - Lifetime
- 2003-02-04 US US10/504,497 patent/US20050119313A1/en not_active Abandoned
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006219488A (ja) * | 2005-01-19 | 2006-08-24 | L'air Liquide Sante Internatl | 衛生的な手の消毒および消毒目的の手の洗浄のための組成物 |
JP2009507891A (ja) * | 2005-09-15 | 2009-02-26 | エール・リキード・サンテ(アンテルナスィオナル) | リポソーム中にカプセル化されたオクテニジン二塩酸塩を含有する抗菌製剤 |
JP2010508251A (ja) * | 2006-10-31 | 2010-03-18 | エール・リキード・サンテ(アンテルナスィオナル) | ビスピリジニウムアルカン(オクテニジンジヒドロクロリド)を含有する抗菌活性組成物 |
JP2011513266A (ja) * | 2008-02-28 | 2011-04-28 | エール・リキード・サンテ(アンテルナスィオナル) | 一定量のビスピリジニウムアルカンを含む、抗菌作用を有する安定化された組成物 |
JP2015187111A (ja) * | 2008-02-28 | 2015-10-29 | エール・リキード・サンテ(アンテルナスィオナル) | 一定量のビスピリジニウムアルカンを含む、抗菌作用を有する安定化された組成物 |
JP2012508725A (ja) * | 2008-11-14 | 2012-04-12 | アルタン ホールディング アクチェンゲゼルシャフト | オクテニジン組成物 |
US8940324B2 (en) | 2008-11-14 | 2015-01-27 | Artan Holding Ag | Octenidine composition |
JP2011236211A (ja) * | 2010-05-07 | 2011-11-24 | Ivoclar Vivadent Ag | 抗菌歯科材料 |
JP2019513793A (ja) * | 2016-04-14 | 2019-05-30 | メリアル インコーポレイテッド | 抗菌性ポリアミド又はオクテニジン保存剤を含むマルチドーズ組成物 |
JP7089479B2 (ja) | 2016-04-14 | 2022-06-22 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | 抗菌性ポリアミド又はオクテニジン保存剤を含むマルチドーズ組成物 |
Also Published As
Publication number | Publication date |
---|---|
DE10205883A1 (de) | 2003-08-21 |
ATE390842T1 (de) | 2008-04-15 |
JP4422487B2 (ja) | 2010-02-24 |
EP1476019A1 (en) | 2004-11-17 |
ES2304519T3 (es) | 2008-10-16 |
EP1476019B1 (en) | 2008-04-02 |
WO2003067988A1 (en) | 2003-08-21 |
DE60320087D1 (de) | 2008-05-15 |
DE60320087T2 (de) | 2009-10-08 |
US20050119313A1 (en) | 2005-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4422487B2 (ja) | ビスピリジニウムアルカンに基づく水性防腐薬 | |
US9750755B2 (en) | Antimicrobial compositions and related methods | |
EP1683417B1 (en) | Disinfectant composition including glycerol monoalkyl ethers and bispyridiniumalkanes and use as skin antiseptic. | |
RU2442567C2 (ru) | Обладающая антимикробной активностью композиция, содержащая биспиридинийалкан (октенидина дигидрохлорид) | |
JPS62292709A (ja) | 皮膚及び粘膜を殺菌するための殺菌剤及び殺菌方法 | |
JP2007536233A (ja) | ポリカチオン抗菌薬による治療 | |
US6525071B2 (en) | Compositions and methods for the treatment and prevention of bovine mastitis | |
JP2001503415A (ja) | 即使用可能なグルタルアルデヒド濃縮物 | |
JP3636611B2 (ja) | 殺菌消毒剤組成物 | |
KR101093992B1 (ko) | 소독 및/또는 살균용 수성 조성물 | |
JP3274223B2 (ja) | 低刺激性d−フェノトリンシャンプー | |
AU2006235798A1 (en) | Topical composition | |
EP3206487B1 (en) | Use of fatty acid ester for improving the antimicrobial efficacy of an alcoholic disinfectant | |
WO2004105745A1 (ja) | オラネキシジン水溶液、その調製方法および消毒剤 | |
JP2022527332A (ja) | 抗菌組成物 | |
US20220218869A1 (en) | Sprayable antimicrobial coatings for wound treatments | |
JP2004352635A (ja) | 消毒および/または殺菌用組成物 | |
RU2246953C1 (ru) | Дезинфицирующее средство | |
JPH10265391A (ja) | 外傷用組成物 | |
JPS6357502A (ja) | 手指消毒用組成物 | |
JPS63264528A (ja) | 医薬組成物 | |
JP3460366B2 (ja) | 口腔用組成物 | |
JP2024519516A (ja) | 消毒剤及びその使用 | |
KR20170003745A (ko) | 클로르헥시딘을 이용한 소동물 치료제 | |
CN118252760A (zh) | 一种消毒杀菌湿巾及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060106 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090714 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091008 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20091104 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20091204 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121211 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4422487 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131211 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |